Hubei Biocause Pharmaceutical (000627) — Cash Flow Quality Index
Hubei Biocause Pharmaceutical (000627) has a Cash Flow Quality Index of 135.70x as of March 2023. Operating cash flow of CN¥6.13 Billion exceeds net income of CN¥45.21 Million, indicating high earnings quality where cash backs reported profits. Explore 000627 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hubei Biocause Pharmaceutical Cash Flow Quality Index (2001–2022)
Historical Cash Flow Quality Index for Hubei Biocause Pharmaceutical across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hubei Biocause Pharmaceutical (000627) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hubei Biocause Pharmaceutical (2001–2022)
Year-by-year earnings quality comparison for Hubei Biocause Pharmaceutical. For live market cap and the full company financial profile, see Hubei Biocause Pharmaceutical (000627) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 27.46x | CN¥7.52 Billion | CN¥274.05 Million | ▲ +209.7% |
| 2021 | 8.86x | CN¥4.17 Billion | CN¥470.71 Million | ▼ -76.0% |
| 2020 | 36.91x | CN¥21.42 Billion | CN¥580.29 Million | ▲ +129.2% |
| 2019 | 16.10x | CN¥28.60 Billion | CN¥1.78 Billion | ▲ +42.6% |
| 2018 | 11.29x | CN¥14.98 Billion | CN¥1.33 Billion | ▲ +3370.4% |
| 2017 | 0.33x | CN¥431.58 Million | CN¥1.33 Billion | ▲ +124.7% |
| 2016 | -1.32x | CN¥-2.34 Billion | CN¥1.78 Billion | ▼ -596.8% |
| 2015 | -0.19x | CN¥-46.73 Million | CN¥247.27 Million | ▼ -102.4% |
| 2012 | 7.93x | CN¥93.79 Million | CN¥11.82 Million | ▲ +0.0% |
| 2010 | 7.93x | CN¥224.58 Million | CN¥28.32 Million | ▲ +569.2% |
| 2007 | 1.19x | CN¥118.56 Million | CN¥100.05 Million | ▼ -55.3% |
| 2006 | 2.65x | CN¥128.19 Million | CN¥48.37 Million | ▼ -61.3% |
| 2005 | 6.85x | CN¥48.66 Million | CN¥7.10 Million | ▼ -37.8% |
| 2004 | 11.01x | CN¥56.07 Million | CN¥5.09 Million | ▲ +999.2% |
| 2001 | 1.00x | CN¥37.30 Million | CN¥37.23 Million | — |